219 related articles for article (PubMed ID: 36500220)
21. Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.
Orr Gandy KA; Adada M; Canals D; Carroll B; Roddy P; Hannun YA; Obeid LM
FASEB J; 2013 Aug; 27(8):3155-66. PubMed ID: 23629860
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine kinase 1 in cancer.
Heffernan-Stroud LA; Obeid LM
Adv Cancer Res; 2013; 117():201-35. PubMed ID: 23290781
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2.
Bergelin N; Blom T; Heikkilä J; Löf C; Alam C; Balthasar S; Slotte JP; Hinkkanen A; Törnquist K
Endocrinology; 2009 May; 150(5):2055-63. PubMed ID: 19116345
[TBL] [Abstract][Full Text] [Related]
24. Short Periods of Hypoxia Upregulate Sphingosine Kinase 1 and Increase Vasodilation of Arteries to Sphingosine 1-Phosphate (S1P) via S1P
Alganga H; Almabrouk TAM; Katwan OJ; Daly CJ; Pyne S; Pyne NJ; Kennedy S
J Pharmacol Exp Ther; 2019 Oct; 371(1):63-74. PubMed ID: 31371480
[TBL] [Abstract][Full Text] [Related]
25. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
[TBL] [Abstract][Full Text] [Related]
27. The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model.
Pinto LC; Soares BM; Pinheiro Jde J; Riggins GJ; Assumpção PP; Burbano RM; Montenegro RC
Toxicol In Vitro; 2015 Dec; 29(8):2038-44. PubMed ID: 26315676
[TBL] [Abstract][Full Text] [Related]
28. The Granuloma Response Controlling Cryptococcosis in Mice Depends on the Sphingosine Kinase 1-Sphingosine 1-Phosphate Pathway.
Farnoud AM; Bryan AM; Kechichian T; Luberto C; Del Poeta M
Infect Immun; 2015 Jul; 83(7):2705-13. PubMed ID: 25895971
[TBL] [Abstract][Full Text] [Related]
29. Endothelial sphingosine kinase/SPNS2 axis is critical for vessel-like formation by human mesoangioblasts.
Laurenzana A; Cencetti F; Serratì S; Bruno G; Japtok L; Bianchini F; Torre E; Fibbi G; Del Rosso M; Bruni P; Donati C
J Mol Med (Berl); 2015 Oct; 93(10):1145-57. PubMed ID: 25952146
[TBL] [Abstract][Full Text] [Related]
30. Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.
Karliner JS
Biochim Biophys Acta; 2013 Jan; 1831(1):203-12. PubMed ID: 22735359
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.
Tsuchida J; Nagahashi M; Nakajima M; Moro K; Tatsuda K; Ramanathan R; Takabe K; Wakai T
J Surg Res; 2016 Sep; 205(1):85-94. PubMed ID: 27621003
[TBL] [Abstract][Full Text] [Related]
32. Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy.
Yaghobian D; Don AS; Yaghobian S; Chen X; Pollock CA; Saad S
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):56-66. PubMed ID: 26414003
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine 1-phosphate signaling in uterine fibroids: implication in activin A pro-fibrotic effect.
Bernacchioni C; Ciarmela P; Vannuzzi V; Greco S; Vannuccini S; Malentacchi F; Pellegrino P; Capezzuoli T; Sorbi F; Cencetti F; Bruni P; Donati C; Petraglia F
Fertil Steril; 2021 Jun; 115(6):1576-1585. PubMed ID: 33500141
[TBL] [Abstract][Full Text] [Related]
34. An Improved Isoform-Selective Assay for Sphingosine Kinase 1 Activity.
Pitman MR; Davies LT; Pitson SM
Methods Mol Biol; 2018; 1697():9-20. PubMed ID: 28540558
[TBL] [Abstract][Full Text] [Related]
35. Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.
Gault CR; Obeid LM
Crit Rev Biochem Mol Biol; 2011 Aug; 46(4):342-51. PubMed ID: 21787121
[TBL] [Abstract][Full Text] [Related]
36. Distinct roles for hematopoietic and extra-hematopoietic sphingosine kinase-1 in inflammatory bowel disease.
Snider AJ; Ali WH; Sticca JA; Coant N; Ghaleb AM; Kawamori T; Yang VW; Hannun YA; Obeid LM
PLoS One; 2014; 9(12):e113998. PubMed ID: 25460165
[TBL] [Abstract][Full Text] [Related]
37. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
[TBL] [Abstract][Full Text] [Related]
38. [The drug development based on sphingosine-1-phosphate signaling pathway].
Bai J; Hu JP
Yao Xue Xue Bao; 2016 Dec; 51(12):1822-8. PubMed ID: 29908533
[TBL] [Abstract][Full Text] [Related]
39. Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells.
Long JS; Edwards J; Watson C; Tovey S; Mair KM; Schiff R; Natarajan V; Pyne NJ; Pyne S
Mol Cell Biol; 2010 Aug; 30(15):3827-41. PubMed ID: 20516217
[TBL] [Abstract][Full Text] [Related]
40. The cross roles of sphingosine kinase 1/2 and ceramide glucosyltransferase in cell growth and death.
Qin J; Kilkus JP; Dawson G
Biochem Biophys Res Commun; 2018 Jun; 500(3):597-602. PubMed ID: 29673590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
